Ir para o conteúdo principal

United States Últimas notícias

Todas as matérias desta categoria, das mais recentes às mais antigas.

Grafa

Context Therapeutics reports positive interim Phase 1a data for ovarian cancer therapy

Context Therapeutics (NASDAQ:CNTX) revealed encouraging preliminary clinical data from its Phase 1a trial evaluating CTIM-76, an investigational bispecific T cell engager designed to target claudin 6 (CLDN6) and engage CD3 T cells.

Leia mais: Context Therapeutics reports positive interim Phase 1a data for ovarian cancer therapy
Grafa

Johnson & Johnson invests over $1 billion to expand Vision operations in Jacksonville

Johnson & Johnson (NYSE:JNJ) has committed more than $1 billion to expand and modernize its Vision care operations in Jacksonville, Florida, targeting increased capacity for its market-leading ACUVUE®-brand contact lenses.

Leia mais: Johnson & Johnson invests over $1 billion to expand Vision operations in Jacksonville